Search
ProQR Therapeutics NV
PRQRAdd to Watchlist
1.710USD
+0.010+0.59%
Close 09-24 16:00（ET）
227.41MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.59%
5 Days
-8.06%
1 Month
-26.92%
6 Months
+10.32%
Year to Date
-15.35%
1 Year
-20.83%
Key Figures
1.700Open
1.890High
96.77KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
1.700Prev. Close
1.665Low
164.09KTurnover
LossP/E Static
2.48P/B
0.00%Div Yield TTM
-36.29%ROA
3.10052wk High
0.16Volume Ratio
-27.76MNet Profit
132.99MShares
-0.3738EPS TTM
0.07Beta
-78.07%ROE
1.33052wk Low
13.23%Amplitude
100.00%Gross Margin
227.41MMarket Cap
1.94Reward/Risk
4.83%Risk Rate
More news coming soon, stay tuned...
ProQR Therapeutics NV's Score
-0.05vs previous score
Forecast8.80
Financial Health8.96
Technical4.73
Valuation Dimensions6.35
Institutional Confidence3.00
Risk Assessment3.27
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
ProQR Therapeutics NV Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.09/-0.13
Revenue / Forecast
10.10M/5.30M
ProQR Therapeutics NV Profile
SectorBiotechnology & Medical Research
Ticker SymbolPRQR
Number of employees166
CountryNetherlands
Ownership
| Shareholders | Proportion |
|---|---|
| Eli Lilly and Company | 16.04% |
| Van Herk Investments | 14.60% |
| Adage Capital Management, L.P. | 5.94% |
| Privium Fund Management BV | 5.19% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 18.88% |
| Corporation | 16.07% |
| Family Office | 14.60% |
| Investment Advisor | 9.37% |
Related Instruments
+2.86%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of ProQR Therapeutics NV (PRQR)?
The current price of ProQR Therapeutics NV (PRQR) is 1.70.
What is the symbol of ProQR Therapeutics NV?
The ticker symbol of ProQR Therapeutics NV is PRQR.
What is the 52-week high of ProQR Therapeutics NV?
The 52-week high of ProQR Therapeutics NV is 3.10.
What is the 52-week low of ProQR Therapeutics NV?
The 52-week low of ProQR Therapeutics NV is 1.33.
What is the market capitalization of ProQR Therapeutics NV?
The market capitalization of ProQR Therapeutics NV is 226.08M.
Is ProQR Therapeutics NV (PRQR) currently rated as Buy, Hold, or Sell?
According to analysts, ProQR Therapeutics NV (PRQR) has an overall rating of Buy, with a price target of 8.90.
What is the Earnings Per Share (EPS TTM) of ProQR Therapeutics NV (PRQR)?
The Earnings Per Share (EPS TTM) of ProQR Therapeutics NV (PRQR) is -0.37.